Gemcitabine-induced drop in platelet counts: A case report

O. Balaji; D. Amita; R. T. Sereen; P. Navin

doi:10.22159/ajpcr.2017.v10i5.17297

Gemcitabine-induced drop in platelet counts: A case report

O. Balaji, D. Amita, R. T. Sereen, P. Navin

Research output: Contribution to journal › Article

Abstract

Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.

Original language	English
Pages (from-to)	17-18
Number of pages	2
Journal	Asian Journal of Pharmaceutical and Clinical Research
Volume	10
Issue number	5
DOIs	https://doi.org/10.22159/ajpcr.2017.v10i5.17297
Publication status	Published - 01-01-2017
Externally published	Yes

Fingerprint

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmaceutical Science
Pharmacology (medical)

Cite this

Balaji, O., Amita, D., Sereen, R. T., & Navin, P. (2017). Gemcitabine-induced drop in platelet counts: A case report. Asian Journal of Pharmaceutical and Clinical Research, 10(5), 17-18. https://doi.org/10.22159/ajpcr.2017.v10i5.17297

@article{fa034e5d688743c193cb51ff608cb393,

title = "Gemcitabine-induced drop in platelet counts: A case report",

abstract = "Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.",

author = "O. Balaji and D. Amita and Sereen, {R. T.} and P. Navin",

year = "2017",

month = "1",

day = "1",

doi = "10.22159/ajpcr.2017.v10i5.17297",

language = "English",

volume = "10",

pages = "17--18",

journal = "Asian Journal of Pharmaceutical and Clinical Research",

issn = "0974-2441",

publisher = "Innovare Academics Sciences Pvt. Ltd",

number = "5",

}

TY - JOUR

T1 - Gemcitabine-induced drop in platelet counts

T2 - A case report

AU - Balaji, O.

AU - Amita, D.

AU - Sereen, R. T.

AU - Navin, P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.

AB - Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=85018745710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018745710&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i5.17297

DO - 10.22159/ajpcr.2017.v10i5.17297

M3 - Article

AN - SCOPUS:85018745710

VL - 10

SP - 17

EP - 18

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 5

ER -

Access to Document

10.22159/ajpcr.2017.v10i5.17297